NC9
NC9 (Cbz-Lys (Acr) -PEG2-dansyl) is an irreversible transglutaminase (TG) inhibitor. NC9 inhibits osteoblast differentiation and mineralization. NC9 destabilizes microtubules. NC9 can be used for the research of osteoblast differentiation[1].
Product Specifications
CAS Number
[1352090-52-8]
Product Name Alternative
Cbz-Lys (Acr) -PEG2-dansyl
UNSPSC
12352005
Target
Glutaminase; Microtubule/Tubulin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/nc9.html
Purity
99.98
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(OCC1=CC=CC=C1)N[C@@H](CCCCNC(C=C)=O)C(NCCOCCOCCNS(=O)(C2=C3C=CC=C(N(C)C)C3=CC=C2)=O)=O
Molecular Formula
C35H47N5O8S
Molecular Weight
697.84
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Rhodopseudomonas palustris ATP synthase subunit b' (atpG)
Recombinant Rhodopseudomonas palustris ATP synthase subunit b' (atpG)
Recombinant Rhodopseudomonas palustris ATP synthase subunit b' (atpG)
ATM, phosphorylated (S1981) (A-T mutated, A-T mutated Homolog, AT complementation group A, AT complementation group C, AT complementation group D, AT complementation group E, AT mutated, AT Protein, AT1, AT1, ATA, Ataxia telangiectasia Gene mutated in human beings, Ataxia telangiectasia mutated, Ataxia telangiectasia mutated Gene, Ataxia telangiectasia mutated Homolog (human), Ataxia telangiectasia mutated Homolog, ATC, ATD, ATDC, ATE, ATM, ATM, DKFZp781A0353, Human phosphatidylinositol 3 Kinase Homolog, MGC74674, OTT) discontinued
ATM, phosphorylated (S1981) (A-T mutated, A-T mutated Homolog, AT complementation group A, AT complementation group C, AT complementation group D, AT complementation group E, AT mutated, AT Protein, AT1, AT1, ATA, Ataxia telangiectasia Gene mutated in human beings, Ataxia telangiectasia mutated, Ataxia telangiectasia mutated Gene, Ataxia telangiectasia mutated Homolog (human), Ataxia telangiectasia mutated Homolog, ATC, ATD, ATDC, ATE, ATM, ATM, DKFZp781A0353, Human phosphatidylinositol 3 Kinase Homolog, MGC74674, OTT) discontinued
